Avanos Medical (AVNS) Non-Current Deferred Tax Liability (2014 - 2026)

Avanos Medical's Non-Current Deferred Tax Liability history runs 13 years deep, the most recent figure standing at $5.6 million for Q1 2026.

• In Q1 2026, Non-Current Deferred Tax Liability changed 0.0% year-over-year to $5.6 million; the TTM figure through Mar 2026 stood at $5.6 million (changed 0.0% YoY), while the FY2025 annual figure was $6.1 million, up 10.91% from the prior year.
• Non-Current Deferred Tax Liability came in at $5.6 million for Q1 2026 at Avanos Medical, down from $6.1 million in the prior quarter.
• In the past five years, Non-Current Deferred Tax Liability ranged from a high of $71.1 million in Q4 2022 to a low of $5.5 million in Q4 2024.
• A 5-year average of $22.5 million and a median of $23.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• Across the five-year window, Non-Current Deferred Tax Liability soared 560.71% in 2022 and tumbled 76.89% in 2024, its largest moves.
• Avanos Medical's Non-Current Deferred Tax Liability stood at $71.1 million in 2022, then tumbled by 66.53% to $23.8 million in 2023, then slumped by 76.89% to $5.5 million in 2024, then advanced by 10.91% to $6.1 million in 2025, then decreased by 8.2% to $5.6 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $5.6 million, $6.1 million, and $6.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison